Substance Use Disorders Clinical Trial
— RENTSOfficial title:
Enhancing Prospective Thinking in Early Recovery
Verified date | February 2024 |
Source | Indiana University |
Contact | Sarah Turo, BA |
Phone | 3179637220 |
sturo[@]iu.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing stimulant use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (StUD) persons. The main question[s] this trial aims to answer are: - Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? - Will the VR intervention produce longer abstinence periods during follow-up visits? - Will the VR intervention increase stimulant drug abstinence rates? - Will the VR intervention increase future self-identification? - Will the VR intervention increase self-reported future time perspective? - Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? - Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
Status | Recruiting |
Enrollment | 88 |
Est. completion date | May 1, 2026 |
Est. primary completion date | May 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Abstinence between =14 days and =1 year - At least 18 years old - Verbal endorsement of commitment to recovery - Outpatient - Psychotropic drugs for SUD-comorbidity - Drug/alcohol abstinence = 24 hours at the time of the study day visit - English comprehension Exclusion Criteria: - Unstable medical disorders - Less than 18 years old - Habitual drug use - Mu-opioid drugs - Smell/taste disorders - Unstable psychiatric conditions - Extravagant/elaborate face tattoos |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University School of Medicine - Goodman Hall | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduced Use of Drug Using Days | The Virtual Reality Avatar experience will reduce drug using days. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Increased Length of Abstinence | The Virtual Reality Avatar experience will increase the length of abstinence periods. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Increased (overall) Abstinence | The Virtual Reality Avatar experience will increase abstinence. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Future Self-identification | The Virtual Reality Avatar experience will increase future self-identification. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Future Time Perspective | The Virtual Reality Avatar experience will increase future time perspective. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Delayed Reward Preference | The Virtual Reality Avatar experience will increase preference for delayed rewards. | Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05660434 -
Using Aromatherapy in Substance Use Disorder
|
N/A | |
Active, not recruiting |
NCT05338268 -
Substance Use and Loneliness
|
N/A | |
Completed |
NCT03954184 -
E-health Implementation (Iowa)
|
N/A | |
Completed |
NCT04098614 -
Barriers to Substance Use Disorder Recovery
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04401215 -
Technologically-Augmented Referrals to Mitigate Addiction Consequences
|
N/A | |
Not yet recruiting |
NCT06187701 -
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Active, not recruiting |
NCT02382042 -
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
|
N/A | |
Completed |
NCT01237366 -
Study Targeting Affect Regulation
|
Phase 1/Phase 2 | |
Terminated |
NCT01356667 -
Drum-Assisted Therapy for Native Americans
|
N/A | |
Completed |
NCT00708890 -
Twelve Step Based Self-help Groups for Substance Related Disorders
|
N/A | |
Active, not recruiting |
NCT04048850 -
Zepatier in Patients With Substance Use
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 |